StockData
Incannex Healthcare Inc. logo

Incannex Healthcare Inc. (IXHL) KPIs and segments

IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.74−0.19 (-9.84%)

Close on Nov 17, 2026Market cap $21.83MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Incannex Healthcare's business

Incannex Healthcare's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Incannex Healthcare's fiscal year ends June 30 — Q4 FY23 = CQ2 2023 (calendar quarter).

Periods
Add to chartMetric
Q4 FY23
Q4 FY22
Q4 FY21
Cannabinoid Products($M)
53.40.260.10
Corporate($M)
34.337.69.22
Psychedelic products($M)
0.880.060.00

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2023-10-31.

See a number that looks wrong?